Becker's Healthcare October 23, 2024
Alexandra Murphy

In 2023, the top 10 drugs purchased under the 340B Drug Pricing Program accounted for roughly one-third of the program’s total spending, according to a Health Resources and Services Administration news release.

Here is a breakdown of the 10 priciest 340B medications:

  1. Keytruda (oncology): $6.91 billion in sales...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article